Submit Deal

23ANDME INC

HQ - San Francisco, California

Summary

23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.

Deals Overview

Total Deals5

Valued Deals4

Total Value£ 3.27 B

Avg. Deal Size£ 818 M

Market Context

Senior Management

Joe Selsavage
Interim CEO
Steve Schoch
CFO
Mark Jensen
Chair of the Board and member of the Special Committee of the Board of Directors

Sort

04 Feb 2021|United States|Biotechnology

Target: 23ANDME INC

Bidder: VG ACQUISITION CORP

11 Service Providers

5 Target | 6 Bidder

39 Dealmakers

24 Target | 16 Bidder

£ 2.56 B

Value

22 Oct 2021|United States|Pharmaceuticals

Target: LEMONAID HEALTH

Bidder: 23ANDME INC

7 Service Providers

3 Target | 4 Bidder

20 Dealmakers

17 Target | 3 Bidder

£ 289 M

Value

18 Apr 2024|United States|Biotechnology

Target: 23ANDME INC

Bidder: ANNE WOJCICKI

5 Service Providers

4 Target | 1 Bidder

10 Dealmakers

8 Target | 2 Bidder

n/a

Value

19 May 2025|United States|Biotechnology

Target: 23ANDME INC

Bidder: REGENERON

6 Service Providers

4 Target | 2 Bidder

26 Dealmakers

7 Target | 19 Bidder

£ 192 M

Value

13 Jun 2025|United States|Biotechnology

Target: 23ANDME INC

Bidder: TTAM RESEARCH INSTITUTE

13 Service Providers

7 Target | 6 Bidder

11 Dealmakers

2 Target | 10 Bidder

£ 224 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Senior Management

Joe Selsavage
Interim CEO
Steve Schoch
CFO
Mark Jensen
Chair of the Board and member of the Special Committee of the Board of Directors